Malaria: all 1,315 studies
Page 8 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Bio-availability of Rectal Artesunate in Children With Severe Falciparum MalariaCompletedNCT02492178Phase 2
- Evaluation of Weekly TafenoquineCompletedNCT02491606Phase 2
- A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium FalciparumCompletedNCT02488902Phase 2
- A Comparison of Diagnostic Approaches for Malaria and PneumoniaStatus unknownNCT02482116
- Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern MyanmarWithdrawnNCT02461186Phase 2/3
- Trial to Compare Effectiveness of 2 Insecticides in Preventing MalariaCompletedNCT02458066Not applicable
- A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)CompletedNCT02453308Phase 2/3
- Severe and Cerebral Malaria Investigated Through Host MetabolomicsCompletedNCT02451904
- Assessing the Effect of Strengthening Referral of Sick Children From the Private Health Sector and Its Impact on Referral Uptake in Uganda.Status unknownNCT02450630Not applicable
- Safety and Tolerability of Low Dose PrimaquineCompletedNCT02434952Phase 4
- Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic MarkersCompletedNCT02427360
- Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean AdultsCompletedNCT02418962Phase 1
- Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric MalariaCompletedNCT02411994Phase 3
- Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)WithdrawnNCT02394522Not applicable
- Effectiveness of Malaria Treatment in MexicoCompletedNCT02394197Phase 4
- Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria IncidenceCompletedNCT02392832Not applicable
- Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum MalariaCompletedNCT02389439Phase 2
- A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265CompletedNCT02389348Phase 1/2
- Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax InfectionStatus unknownNCT02364583Phase 4
- Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated MalariaCompletedNCT02353494
- Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in MalaysiaStatus unknownNCT02348788Phase 3
- Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and MaliCompletedNCT02334462Phase 1
- Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern ZambiaCompletedNCT02329301Not applicable
- Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, IndonesiaCompletedNCT02325180Phase 4
- Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in SwazilandCompletedNCT02315690Phase 3
- Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi MosquitoesCompletedNCT02313376Phase 1
- Providers' Compliance to Malaria TreatmentStatus unknownNCT02298140Not applicable
- The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in CambodiaStatus unknownNCT02297477Phase 4
- Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - TanzaniaWithdrawnNCT02294214Not applicable
- Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - KenyaWithdrawnNCT02294201Not applicable
- Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - IndonesiaCompletedNCT02294188Not applicable
- Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray ProductCompletedNCT02288637Not applicable
- Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria TransmissionCompletedNCT02259426Phase 3
- A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,SCompletedNCT02252640Phase 1/2
- Dolutegravir Interactions With Artemisinin-based Combination TherapiesCompletedNCT02242799Phase 1
- Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ ChallengeCompletedNCT02237586Phase 1
- A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of DosesCompletedNCT02215707Phase 1
- School-based Programme of Malaria Diagnosis and Treatment in Southern MalawiCompletedNCT02213211Not applicable
- A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African ChildrenCompletedNCT02211729Phase 3
- Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in MaliCompletedNCT02206451
- Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail SectorCompletedNCT02199977Not applicable
- Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and TanzaniaStatus unknownNCT02199951
- Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum MalariaStatus unknownNCT02198807Phase 2
- A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine TetraphosphateCompletedNCT02184637Phase 1
- A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5CompletedNCT02181088Phase 1
- Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve AdultsCompletedNCT02174978Phase 1
- Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)CompletedNCT02174900Phase 2/3
- In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican ChildrenCompletedNCT02168569Phase 4
- Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United StatesTerminatedNCT02153996
- Home Management of Malaria and PneumoniaCompletedNCT02151578Phase 4
- Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum StrainsCompletedNCT02149550Not applicable
- Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and MorbidityCompletedNCT02143934Phase 4
- Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian AdultsCompletedNCT02132299Phase 1
- DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or VivaxCompletedNCT02123290Phase 2
- Malaria Clinical Trials Center General ScreeningCompletedNCT02119312
- Iron and Prebiotics Fortification in Kenyan InfantsCompletedNCT02118402Not applicable
- Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:CompletedNCT02118090Phase 4
- Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under ChemoprophylaxisCompletedNCT02115516Phase 1
- Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax MalariaTerminatedNCT02110784Phase 2
- Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous InfectionCompletedNCT02098590Not applicable
- Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in UgandaCompletedNCT02094508
- Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With MalariaCompletedNCT02092766Phase 4
- Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of GametocytesCompletedNCT02090036Phase 4
- Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.CompletedNCT02089841Phase 4
- A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian InfantsCompletedNCT02083887Phase 1
- Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium VivaxCompletedNCT02083068Phase 2
- Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under ChemoprophylaxisCompletedNCT02080026Not applicable
- Harmonized AS/MQ Efficacy Study - ThailandCompletedNCT02052323Phase 4
- A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum MalariaCompletedNCT02044198Phase 1/2
- Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 DayCompletedNCT02020330Phase 3
- Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive AdultsCompletedNCT02015091Phase 1
- School-Based Treatment With ACT to Reduce TransmissionCompletedNCT02009215Phase 4
- Malaria in Early Life StudyCompletedNCT02001428Not applicable
- P. Knowlesi Trial of Artemether-lumefantrine vs ChloroquineCompletedNCT02001012Phase 3
- Immunization Via Mosquito Bite With Radiation-attenuated SporozoitesCompletedNCT01994525Phase 1
- A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum MalariaCompletedNCT01992900Phase 2
- Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African AdultsCompletedNCT01988636Phase 1
- In Vivo and In Vitro Efficacy of Artemisinin Combination TherapyCompletedNCT01976780Phase 4
- Evaluating the Ottawa Malaria Decision AidStatus unknownNCT01976325Not applicable
- Adherence to Antimalarial Drugs in Sierra LeoneCompletedNCT01967472Not applicable
- Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/IbCompletedNCT01949909Phase 1
- Community-based Screening and Treatment of Malaria in Pregnancy: a Cluster-randomized TrialCompletedNCT01941264Not applicable
- Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)CompletedNCT01939886Phase 3
- Optimal Fluid Management in Adult Severe MalariaCompletedNCT01936766
- Low Dose Primaquine for Clearance of GametocytesCompletedNCT01935882Phase 2/3
- Safety, Tolerability, Pharmacokinetics and Efficacy of ARCOCompletedNCT01930331Phase 4
- Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)CompletedNCT01921413
- Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in PregnancyCompletedNCT01916954Phase 3
- The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community LevelCompletedNCT01907672Phase 4
- The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination TherapyStatus unknownNCT01906788Phase 4
- Malaria Survey in the Tak Province Refugee CampsCompletedNCT01902797Not applicable
- Evaluation of the Efficacy of Artemisinin Combination Therapy in KenyaStatus unknownNCT01899820Phase 3
- Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in VietnamCompletedNCT01887821Phase 4
- A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,SCompletedNCT01883609Phase 1/2
- Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus PrimaquineCompletedNCT01878357Phase 4
- Targeted Chemo-elimination (TCE) of MalariaCompletedNCT01872702Not applicable
- Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking VaccineCompletedNCT01867463Phase 1
- Collection of Biological Material From Pregnant Women in a Malarial RegionTerminatedNCT01862783
- Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone SuspensionCompletedNCT01858831Phase 1
- Antimalarial Drug Resistance With Assessment of Transmission Blocking ActivitySuspendedNCT01849640Not applicable